Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Peired, Anna Julie ^a,b   Sisti, Alessandro ^a,c   Romagnani, Paola ^a,b,c  

^a Transfer and High Education for the Development of De Novo Therapies (DENOTHE)   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL HOMING; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONSENSUS DEVELOPMENT; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; ENGRAFTMENT; EVIDENCE BASED PRACTICE; FEASIBILITY STUDY; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HUMAN; IMMUNOMODULATION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTICENTER STUDY (TOPIC); NONHUMAN; PARACRINE SIGNALING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY EFFECT;

EID: 84990866147     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/4798639     Document Type: Review

References (148)

1. A. J. Friedenstein, I. I. Piatetzky-Shapiro, and K. V. Petrakova, "Osteogenesis in transplants of bone marrow cells, " Journal of Embryology and Experimental Morphology, vol. 16, no. 3, pp. 381-390, 1966.
2. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease, " Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008.
3. K. Le Blanc and D. Mougiakakos, "Multipotent mesenchymal stromal cells and the innate immune system, " Nature Reviews Immunology, vol. 12, no. 5, pp. 383-396, 2012.
4. M. Morigi and A. Benigni, "Mesenchymal stemcells and kidney repair, " Nephrology Dialysis Transplantation, vol. 28, no. 4, pp. 788-793, 2013.
5. M. Kassem, L. Mosekilde, and E. F. Eriksen, "1, 25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells, " Journal of Bone and Mineral Research, vol. 8, no. 12, pp. 1453-1458, 1993.
6. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for CellularTherapy position statement, " Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
7. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
8. H.-T. Zhang, Z.-L. Liu, X.-Q. Yao, Z.-J. Yang, and R.-X. Xu, "Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: A comparative study, " Cytotherapy, vol. 14, no. 10, pp. 1203-1214, 2012.
9. P. Bianco, X. Cao, P. S. Frenette et al., "The meaning, the sense and the significance: Translating the science of mesenchymal stem cells intomedicine, " Nature Medicine, vol. 19, no. 1, pp. 35-42, 2013.
10. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., "Pluripotency ofmesenchymal stemcells derived from adultmarrow, " Nature, vol. 418, no. 6893, pp. 41-49, 2002.
11. P. Bourin, B. A. Bunnell, L. Casteilla et al., "Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society forCellularTherapy (ISCT), " Cytotherapy, vol. 15, no. 6, pp. 641-648, 2013.
12. G. Grisendi, C. Annerén, L. Cafarelli et al., "GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion, " Cytotherapy, vol. 12, no. 4, pp. 466-477, 2010.
13. M. Krampera, J. Galipeau, Y. Shi, K. Tarte, and L. Sensebe, "Immunological characterization of multipotent mesenchymal stromal cells-the International Society for Cellular Therapy (ISCT) working proposal, " Cytotherapy, vol. 15, no. 9, pp. 1054-1061, 2013.
14. U. Galderisi, A. Calarco, M. A. B. Melone, and G. Peluso, "Is it possible to improve the success rate of cellular therapy based on mesenchymal stem cells" Journal of Stem Cells Research, Reviews & Reports, vol. 1, pp. 1017-1019, 2014.
15. J. Campisi and F. D'Adda Di Fagagna, "Cellular senescence: when bad things happen to good cells, " Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729-740, 2007.
16. K. Le Blanc, F. Frassoni, L. Ball et al., "Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versushost disease: A phase II study, " The Lancet, vol. 371, no. 9624, pp. 1579-1586, 2008.
17. T. Squillaro, G. Peluso, and U. Galderisi, "Clinical trials with mesenchymal stem cells: An update, " Cell Transplantation, vol. 25, no. 5, pp. 829-848, 2016.
18. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, "Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors, " Stem Cells, vol. 23, no. 2, pp. 220-229, 2005.
19. S. Gronthos, M. Mankani, J. Brahim, P. G. Robey, and S. Shi, "Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13625-13630, 2000.
20. M. La Noce, F. Paino, A. Spina et al., "Dental pulp stem cells: state of the art and suggestions for a true translation of research into therapy, " Journal of Dentistry, vol. 42, no. 7, pp. 761-768, 2014.
21. A. J. Kermani, F. Fathi, and S. J. Mowla, "Characterization and genetic manipulation of human umbilical cord vein mesenchymal stemcells: potential application in cell-based gene therapy, " Rejuvenation Research, vol. 11, no. 2, pp. 379-386, 2008.
22. P. A. Zuk, M. Zhu, H. Mizuno et al., "Multilineage cells from human adipose tissue: implications for cell-based therapies, " Tissue Engineering, vol. 7, no. 2, pp. 211-228, 2001.
23. S. Gronthos and A. C. W. Zannettino, "Methods for the purification and characterization of human adipose-derived stem cells, " Methods in Molecular Biology, vol. 702, pp. 109-120, 2011.
24. H. Orbay, M. Tobita, and H. Mizuno, "Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications, " Stem Cells International, vol. 2012, Article ID 461718, 9 pages, 2012.
25. P. S. In 't Anker, S. A. Scherjon, C. Kleijburg-van der Keur et al., "Amniotic fluid as a novel source of mesenchymal stemcells for therapeutic transplantation, " Blood, vol. 102, no. 4, pp. 1548-1549, 2003.
26. M.-S. Tsai, J.-L. Lee, Y.-J. Chang, and S.-M. Hwang, "Isolation of human multipotent mesenchymal stem cells from secondtrimester amniotic fluid using a novel two-stage culture protocol, " Human Reproduction, vol. 19, no. 6, pp. 1450-1456, 2004.
27. S. Bruno, B. Bussolati, C. Grange et al., "Isolation and characterization of resident mesenchymal stem cells in human glomeruli, " Stem Cells and Development, vol. 18, no. 6, pp. 867-880, 2009.
28. J. Li, U. Ariunbold, N. Suhaimi et al., "Collecting duct-derived cells display mesenchymal stem cell properties and retain selective in vitro and in vivo epithelial capacity, " Journal of the American Society of Nephrology, vol. 26, no. 1, pp. 81-94, 2015.
29. R. A. Pelekanos, J. Li, M. Gongora et al., "Comprehensive transcriptome and immunophenotype analysis of renal and cardiacMSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities, " Stem Cell Research, vol. 8, no. 1, pp. 58-73, 2012.
30. M. Crisan, S. Yap, L. Casteilla et al., "A perivascular origin for mesenchymal stem cells in multiple human organs, " Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
31. R. G. Edwards and P. Hollands, "Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation" Reproductive BioMedicine Online, vol. 14, no. 3, pp. 396-401, 2007.
32. A. Flynn, F. Barry, and T. O'Brien, "UC blood-derived mesenchymal stromal cells: An overview, " Cytotherapy, vol. 9, no. 8, pp. 717-726, 2007.
33. D. Wang, J. Li, Y. Zhang et al., "Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: A multicenter clinical study, " Arthritis Research &Therapy, vol. 16, no. 2, article R79, 2014.
34. Y. Tang, H. Xie, J. Chen et al., "ActivatedNF-B in bonemarrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling, " Stem Cells and Development, vol. 22, no. 4, pp. 668-678, 2013.
35. X. Li, L. Liu, D. Meng et al., "Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus, " Stem Cells and Development, vol. 21, no. 13, pp. 2387-2394, 2012.
36. M.-C. Kastrinaki, P. Sidiropoulos, S. Roche et al., "Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 741-749, 2008.
37. S. Guiducci, M. Manetti, E. Romano et al., "Bone marrowderived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrinemachinery and stimulate angiogenesis in vitro, " Annals of the RheumaticDiseases, vol. 70, no. 11, pp. 2011-2021, 2011.
38. A. Subramanian, G. Shu-Uin, N. Kae-Siang et al., "Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells, " Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 1886-1895, 2012.
39. T. A. Moseley, M. Zhu, and M. H. Hedrick, "Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery, " Plastic and Reconstructive Surgery, vol. 118, no. 3, pp. 121S-128S, 2006.
40. F. Bortolotti, L. Ukovich, V. Razban et al., "In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure, " Stem Cell Reports, vol. 4, no. 3, pp. 332-339, 2015.
41. F. Ezquer, M. Giraud-Billoud, D. Carpio, F. Cabezas, P. Conget, and M. Ezquer, "Proregenerative microenvironment triggered by donor mesenchymal stem cells preserves renal function and structure in mice with severe diabetes mellitus, " BioMed Research International, vol. 2015, Article ID 164703, 23 pages, 2015.
42. M. Rahman, F. Shad, and M. C. Smith, "Acute kidney injury: A guide to diagnosis and management, " American Family Physician, vol. 86, no. 7, pp. 631-639, 2012.
43. H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al., "Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638-14643, 2008.
44. M. K. Crow, "Developments in the clinical understanding of lupus, " Arthritis Research & Therapy, vol. 11, no. 5, article 245, 2009.
45. F. A. Houssiau and E. M. Ginzler, "Current treatment of lupus nephritis, " Lupus, vol. 17, no. 5, pp. 426-430, 2008.
46. H. Munir and H. M. McGettrick, "Mesenchymal stem cell therapy for autoimmune disease: risks and rewards, " Stem Cells and Development, vol. 24, no. 18, pp. 2091-2100, 2015.
47. L. Sun, K. Akiyama, H. Zhang et al., "Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans, " Stem Cells, vol. 27, no. 6, pp. 1421-1432, 2009.
48. A. Pileggi, X. Xu, J. Tan, and C. Ricordi, "Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials, " Current Opinion in Organ Transplantation, vol. 18, no. 6, pp. 672-681, 2013.
49. K. E. Lamb, S. Lodhi, and H.-U. Meier-Kriesche, "Longterm renal allograft survival in the United States: A critical reappraisal, " American Journal of Transplantation, vol. 11, no. 3, pp. 450-462, 2011.
50. M. E. J. Reinders, T. J. Rabelink, and J. W. de Fijter, "The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation, " Current Opinion in Organ Transplantation, vol. 18, no. 1, pp. 44-50, 2013.
51. L. Sun, D. Wang, J. Liang et al., "Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus, " Arthritis & Rheumatism, vol. 62, no. 8, pp. 2467-2475, 2010.
52. J. Tan, W. Wu, X. Xu et al., "Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial, " The Journal of the American Medical Association, vol. 307, no. 11, pp. 1169-1177, 2012.
53. N. Perico, F. Casiraghi, E. Gotti et al., "Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation, " Transplant International, vol. 26, no. 9, pp. 867-878, 2013.
54. A. Chapel, J. M. Bertho, M. Bensidhoum et al., "Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome, " Journal of Gene Medicine, vol. 5, no. 12, pp. 1028-1038, 2003.
55. A. Mahmood, D. Lu, M. Lu, andM. Chopp, "Treatment of traumatic brain injury in adult rats with intravenous administration of human bonemarrow stromal cells, " Neurosurgery, vol. 53, no. 3, pp. 697-703, 2003.
56. A. Monsel, Y.-G. Zhu, S. Gennai, Q. Hao, J. Liu, and J. W. Lee, "Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells, " Anesthesiology, vol. 121, no. 5, pp. 1099-1121, 2014.
57. X. Wei, X. Yang, Z.-P. Han, F.-F. Qu, L. Shao, and Y.-F. Shi, "Mesenchymal stem cells: A new trend for cell therapy, " Acta Pharmacologica Sinica, vol. 34, no. 6, pp. 747-754, 2013.
58. V. Göransson, C. Johnsson, A. Jacobson, P. Heldin, R. Hällgren, and P. Hansell, "Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat, " Nephrology Dialysis Transplantation, vol. 19, no. 4, pp. 823-830, 2004.
59. M. B. Herrera, B. Bussolati, S. Bruno et al., "Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury, " Kidney International, vol. 72, no. 4, pp. 430-441, 2007.
60. S.-C. Hung, R. R. Pochampally, S.-C. Hsu et al., "Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo, " PLoS ONE, vol. 2, article e416, 2007.
61. N. Liu, J. Tian, J. Cheng, and J. Zhang, "Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney, " Journal of Cellular Biochemistry, vol. 114, no. 12, pp. 2677-2689, 2013.
62. C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth, "MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of humanmesenchymal stem cells: differential regulation by inflammatory cytokines, " Blood, vol. 109, no. 9, pp. 4055-4063, 2007.
63. X. Si, X. Liu, J. Li, and X. Wu, "Transforming growth factor-1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury, " International Journal of Clinical and Experimental Pathology, vol. 8, pp. 12368-12378, 2015.
64. X.-Y. Si, J.-J. Li, T. Yao, and X.-Y. Wu, "Transforming growth factor-1 in the microenvironment of ischemia reperfusioninjured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4, " Molecular Medicine Reports, vol. 9, no. 5, pp. 1794-1798, 2014.
65. A. Sohni and C. M. Verfaillie, "Mesenchymal stem cells migration homing and tracking, " Stem Cells International, vol. 2013, Article ID 130763, 8 pages, 2013.
66. F. Tögel, J. Isaac, Z. Hu, K. Weiss, and C. Westenfelder, "Renal SDF-1 signalsmobilization and homing ofCXCR4-positive cells to the kidney after ischemic injury, " Kidney International, vol. 67, no. 5, pp. 1772-1784, 2005.
67. G. Wang, Q. Zhang, Z. Zhuo et al., "Enhanced homing of CXCR-4 modified bone marrow-derived mesenchymal stem cells to acute kidney injury tissues by micro-bubble-mediated ultrasound exposure, " Ultrasound in Medicine and Biology, vol. 42, no. 2, pp. 539-548, 2016.
68. M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau, "Paracrine mechanisms in adult stem cell signaling and therapy, " Circulation Research, vol. 103, no. 11, pp. 1204-1219, 2008.
69. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder, "Administered mesenchymal stemcells protect against ischemic acute renal failure through differentiation-independentmechanisms, " American Journal of Physiology-Renal Physiology, vol. 289, no. 1, pp. F31-F42, 2005.
70. J. S. Duffield and J. V. Bonventre, "Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury, " Kidney International, vol. 68, no. 5, pp. 1956-1961, 2005.
71. J. S. Duffield, K. M. Park, L.-L. Hsiao et al., "Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells, " The Journal of Clinical Investigation, vol. 115, no. 7, pp. 1743-1755, 2005.
72. M. H. Jiang, G. Li, J. Liu et al., "Nestin+ kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury, " Biomaterials, vol. 50, no. 1, pp. 56-66, 2015.
73. K. W. Liechty, T. C. Mackenzie, A. F. Shaaban et al., "Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep, " Nature Medicine, vol. 6, no. 11, pp. 1282-1286, 2000.
74. F. Casiraghi, G. Remuzzi, and N. Perico, "Mesenchymal stromal cells to promote kidney transplantation tolerance, " Current Opinion in Organ Transplantation, vol. 19, no. 1, pp. 47-53, 2014.
75. F. Casiraghi, N. Perico, M. Cortinovis, and G. Remuzzi, "Mesenchymal stromal cells in renal transplantation: opportunities and challenges, " Nature Reviews Nephrology, vol. 12, no. 4, pp. 241-253, 2016.
76. K. Le Blanc, C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringdén, "HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, " Experimental Hematology, vol. 31, no. 10, pp. 890-896, 2003.
77. J. M. Ryan, F. P. Barry, J. M. Murphy, and B. P. Mahon, "Mesenchymal stem cells avoid allogeneic rejection, " Journal of Inflammation, vol. 2, article 8, 2005.
78. L. Chen, E. E. Tredget, P. Y. G. Wu, andY. Wu, "Paracrine factors of mesenchymal stemcells recruitmacrophages and endothelial lineage cells and enhance wound healing, " PLoS ONE, vol. 3, no. 4, Article ID e1886, 2008.
79. M.-H. Chien, M.-Y. Bien, C.-C. Ku et al., "Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury, " Critical CareMedicine, vol. 40, no. 4, pp. 1245-1253, 2012.
80. M. D. Nicola, C. Carlo-Stella, M. Magni et al., "Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, " Blood, vol. 99, no. 10, pp. 3838-3843, 2002.
81. L. Ionescu, R. N. Byrne, T. van Haaften et al., "Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action, " American Journal of Physiology-Lung Cellular andMolecular Physiology, vol. 303, no. 11, pp. L967-L977, 2012.
82. E. Jang, M. Jeong, S. Kim et al., "Infusion of human bone marrow-derived mesenchymal stem cells alleviates autoimmune nephritis in a lupusmodel by suppressing follicular helper T-cell development, " Cell Transplantation, vol. 25, no. 1, pp. 1-15, 2016.
83. X.-X. Jiang, Y. Zhang, B. Liu et al., "Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells, " Blood, vol. 105, no. 10, pp. 4120-4126, 2005.
84. E. S. Kim, Y. S. Chang, S. J. Choi et al., "Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice, " Respiratory Research, vol. 12, article108, 2011.
85. M. Krampera, S. Glennie, J. Dyson et al., "Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, " Blood, vol. 101, no. 9, pp. 3722-3729, 2003.
86. K. Le Blanc, L. Tammik, B. Sundberg, S. E. Haynesworth, andO. Ringdén, "Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures andmitogenic responses independently of the major histocompatibility complex, " Scandinavian Journal of Immunology, vol. 57, no. 1, pp. 11-20, 2003.
87. Z.-X. Liang, J.-P. Sun, P. Wang, Q. Tian, Z. Yang, andL.-A. Chen, "Bone marrow-derived mesenchymal stem cells protect rats from endotoxin-induced acute lung injury, " Chinese Medical Journal, vol. 124, no. 17, pp. 2715-2722, 2011.
88. A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe, "Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells, " The Journal of Immunology, vol. 177, no. 4, pp. 2080-2087, 2006.
89. K. Németh, A. Leelahavanichkul, P. S. T. Yuen et al., "Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production, " Nature Medicine, vol. 15, no. 1, pp. 42-49, 2009.
90. A. Poggi, C. Prevosto, A.-M. Massaro et al., "Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors, " Journal of Immunology, vol. 175, no. 10, pp. 6352-6360, 2005.
91. I. Rasmusson, O. Ringdén, B. Sundberg, and K. Le Blanc, "Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells, " Transplantation, vol. 76, no. 8, pp. 1208-1213, 2003.
92. G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, "Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, " Blood, vol. 107, no. 4, pp. 1484-1490, 2006.
93. J. Sun, Z.-B. Han, W. Liao et al., "Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti-and proinflammatory factors, " Cellular Physiology and Biochemistry, vol. 27, no. 5, pp. 587-596, 2011.
94. Q.-Z. Zhang, W.-R. Su, S.-H. Shi et al., "Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing, " STEM CELLS, vol. 28, no. 10, pp. 1856-1868, 2010.
95. J. A. Zullo, E. P. Nadel, M. M. Rabadi et al., "The secretome of hydrogel-coembedded endothelial progenitor cells and mesenchymal stem cells instructs macrophage polarization in endotoxemia, " Stem Cells Translational Medicine, vol. 4, no. 7, pp. 852-861, 2015.
96. U. Galderisi and A. Giordano, "Thegap between the physiological and therapeutic roles of mesenchymal stem cells, " Medicinal Research Reviews, vol. 34, no. 5, pp. 1100-1126, 2014.
97. M. E. Bernardo and W. E. Fibbe, "Mesenchymal stromal cells: sensors and switchers of inflammation, " Cell Stem Cell, vol. 13, no. 4, pp. 392-402, 2013.
98. Y. Chen, H. Qian, W. Zhuet al., "Hepatocytegrowthfactormodification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury, " Stem Cells and Development, vol. 20, no. 1, pp. 103-113, 2011.
99. F. Tögel, P. Zhang, Z. Hu, and C. Westenfelder, "VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury, " Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 2109-2114, 2009.
100. B. Imberti, M. Morigi, S. Tomasoni et al., "Insulin-like growth factor-1 sustains stem cell-mediated renal repair, " Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2921-2928, 2007.
101. J. Zhang, Y. Li, J. Chen et al., "Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells, " Brain Research, vol. 1030, no. 1, pp. 19-27, 2004.
102. S. B. Miller, D. R. Martin, J. Kissane, and M. R. Hammerman, "Insulin-like growth factor I accelerates recovery fromischemic acute tubular necrosis in the rat, " Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 11876-11880, 1992.
103. S. B. Miller, D. R. Martin, J. Kissane, and M. R. Hammerman, "Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats, " American Journal of Physiology, vol. 266, no. 1, pp. F129-F134, 1994.
104. B. F. Schrijvers, A. Flyvbjerg, and A. S. De Vriese, "The role of vascular endothelial growth factor (VEGF) in renal pathophysiology, " Kidney International, vol. 65, no. 6, pp. 2003-2017, 2004.
105. Y. Zhou, H. Xu, W. Xu et al., "Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro, " Stem Cell Research andTherapy, vol. 4, article 34, 2013.
106. B. Thébaud and D. J. Stewart, "Exosomes: cell garbage can, therapeutic carrier, or trojan horse" Circulation, vol. 126, no. 22, pp. 2553-2555, 2012.
107. S. Bruno, C. Grange, F. Collino et al., "Microvesicles derived frommesenchymal stem cells enhance survival in a lethalmodel of acute kidney injury, " PLoSONE, vol. 7, no. 3, Article IDe33115, 2012.
108. F. Collino, M. C. Deregibus, S. Bruno et al., "Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs, " PLoS ONE, vol. 5, no. 7, Article ID e11803, 2010.
109. S. Bruno, C. Grange, M. C. Deregibus et al., "Mesenchymal stem cell-derived microvesicles protect against acute tubular injury, " Journal of theAmerican Society of Nephrology, vol. 20, no. 5, pp. 1053-1067, 2009.
110. G.-Q. Ju, J. Cheng, L. Zhong et al., "Microvesicles derived from human umbilical cord mesenchymal stemcells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction, " PLoS ONE, vol. 10, no. 3, Article ID e0121534, 2015.
111. D. W. Zhang, H. Qiu, Y. M. Mei, H. Fu, and H. G. Zheng, "Repair effects of umbilical cord mesenchymal stem cells on podocytedamage of iga nephropathy, " Journal of Biological Regulators and Homeostatic Agents, vol. 29, no. 3, pp. 609-617, 2015.
112. M. G. Monteiro Carvalho Mori da Cunha, S. Zia, F. Oliveira Arcolino et al., "Amniotic fluid derived stem cells with a renal progenitor phenotype inhibit interstitial fibrosis in renal ischemia and reperfusion injury in rats, " PLoS ONE, vol. 10, no. 8, Article ID e0136145, 2015.
113. A. F. da Silva, K. Silva, L. A. Reis, V. P. C. Teixeira, and N. Schor, "Bone marrow-derived mesenchymal stem cells and their conditioned medium attenuate fibrosis in an irreversible model of unilateral ureteral obstruction, " Cell Transplantation, vol. 24, no. 12, pp. 2657-2666, 2015.
114. M. Mohammadzadeh, R. Halabian, A. Gharehbaghian et al., "Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity, " Cell Stress and Chaperones, vol. 17, no. 5, pp. 553-565, 2012.
115. F. Arslan, R. C. Lai, M. B. Smeets et al., "Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury, " Stem Cell Research, vol. 10, no. 3, pp. 301-312, 2013.
116. R. Bellomo, J. A. Kellum, and C. Ronco, "Acute kidney injury, " The Lancet, vol. 380, no. 9843, pp. 756-766, 2012.
117. F. E. Tögel and C. Westenfelder, "Kidney protection and regeneration following acute injury: progress through stem cell therapy, "American Journal of Kidney Diseases, vol. 60, no. 6, pp. 1012-1022, 2012.
118. A. Gooch, J. Doty, J. Flores et al., "Initial report on a phase I clinical trial: prevention and treatment of post-operative Acute Kidney Injury with allogeneic Mesenchymal Stem Cells in patients who require on-pump cardiac surgery, " Cellular Therapy and Transplantation, vol. 1, no. 2, pp. 31-35, 2008.
119. F. Bianchi, E. Sala, C. Donadei, I. Capelli, and G. La Manna, "Potential advantages of acute kidney injury management by mesenchymal stem cells, "World Journal of StemCells, vol. 6, no. 5, pp. 644-650, 2014.
120. K. Brück, V. S. Stel, S. Fraser et al., "Translational research in nephrology: chronic kidney disease prevention and public health, " Clinical Kidney Journal, vol. 8, no. 6, pp. 647-655, 2015.
121. D. A. Papazova, N. R. Oosterhuis, H. Gremmels, A. van Koppen, J. A. Joles, and M. C. Verhaar, "Cell-based therapies for experimental chronic kidney disease: A systematic review and meta-analysis, " Disease Models and Mechanisms, vol. 8, no. 3, pp. 281-293, 2015.
122. H. Gallagher and R. J. Suckling, "Diabetic nephropathy: where are we on the journey from pathophysiology to treatment" Diabetes, Obesity and Metabolism, vol. 18, no. 7, pp. 641-647, 2016.
123. M. E. Ezquer, F. E. Ezquer, M. L. Arango-Rodrguez, and P. A. Conget, "MSCtransplantation: A promising therapeutic strategy to manage the onset and progression of diabetic nephropathy, " Biological Research, vol. 45, no. 3, pp. 289-296, 2012.
124. L. Malaga-Dieguez, D. Bouhassira, D. Gipson, and H. Trachtman, "Novel therapies for FSGS: preclinical and clinical studies, " Advances in Chronic Kidney Disease, vol. 22, no. 2, pp. e1-e6, 2015.
125. H. Ma, Y. Wu, Y. Xu, L. Sun, and X. Zhang, "Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis, " American Journal of the Medical Sciences, vol. 346, no. 6, pp. 486-493, 2013.
126. M. Belingheri, L. Lazzari, V. Parazzi et al., "Allogeneic mesenchymal stem cell infusion for the stabilization offocal segmental glomerulosclerosis, " Biologicals, vol. 41, no. 6, pp. 439-445, 2013.
127. J. Liang, H. Zhang, B. Hua et al., "Allogenicmesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study, " Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1423-1429, 2010.
128. D. Wang, X. Feng, L. Lu et al., "A CD8 T cell/indoleamine 2, 3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus, " Arthritis & Rheumatology, vol. 66, no. 8, pp. 2234-2245, 2014.
129. N. Perico, F. Casiraghi, M. Introna et al., "Autologousmesenchymal stromal cells and kidney transplantation: A pilot study of safety and clinical feasibility, " Clinical Journal of the American Society of Nephrology, vol. 6, no. 2, pp. 412-422, 2011.
130. M. E. J. Reinders, J. W. de Fijter, H. Roelofs et al., "Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study, " Stem Cells Translational Medicine, vol. 2, no. 2, pp. 107-111, 2013.
131. M. E. J. Reinders, J. R. Bank, G. J. Dreyer et al., "Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients, " Journal of Translational Medicine, vol. 12, article 331, 2014.
132. M. E. J. Reinders, G. J. Dreyer, J. R. Bank et al., "Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: The neptune study, " Journal of TranslationalMedicine, vol. 13, no. 1, article 344, 2015.
133. C. Mudrabettu, V. Kumar, A. Rakha et al., "Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study, " Nephrology, vol. 20, no. 1, pp. 25-33, 2015.
134. A. V. Vanikar, H. L. Trivedi, A. Feroze, K. V. Kanodia, S. D. Dave, andP. R. Shah, "Effect of co-transplantationofmesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness, " International Urology and Nephrology, vol. 43, no. 1, pp. 225-232, 2011.
135. A. V. Vanikar and H. L. Trivedi, "Stem cell transplantation in living donor renal transplantation for minimization of immunosuppression, " Transplantation, vol. 94, no. 8, pp. 845-850, 2012.
136. H. Lee, J. B. Park, S. Lee, S. Baek, H. Kim, and S. J. Kim, "Intraosseous injection of donor mesenchymal stem cell (MSC) into the bonemarrow in living donor kidney transplantation; a pilot study, " Journal of TranslationalMedicine, vol. 11, no. 1, article 96, 2013.
137. Y. Peng, M. Ke, L. Xu et al., "Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: A clinical pilot study, " Transplantation, vol. 95, no. 1, pp. 161-168, 2013.
138. M. Mastri, H. Lin, and T. Lee, "Enhancing the efficacy of mesenchymal stem cell therapy, " World Journal of Stem Cells, vol. 6, no. 2, pp. 82-93, 2014.
139. Y. S. Kim, J. S. Kwon, M. H. Hong et al., "Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin, " BMC Cell Biology, vol. 14, no. 1, article 38, 2013.
140. S. R. Wallace, M. M. Oken, K. L. Lunetta, A. Panoskaltsis-Mortari, and A. M. Masellis, "Abnormalities of bone marrowmesenchymal cells in multiple myeloma patients, " Cancer, vol. 91, no. 7, pp. 1219-1230, 2001.
141. K. Kemp, R. Morse, S. Wexler et al., "Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy, " Annals of Hematology, vol. 89, no. 7, pp. 701-713, 2010.
142. B. Bozkurt andM. Kiliç, "Marginal donors in renal transplantation, " Transplantation Proceedings, vol. 47, no. 5, pp. 1273-1281, 2015.
143. G. Gopalakrishnan and S. P. Gourabathini, "Marginal kidney donor, " Indian Journal of Urology, vol. 23, no. 3, pp. 286-293, 2007.
144. M. Morigi, C. Rota, and G. Remuzzi, "Mesenchymal stem cells in kidney repair, " in Mesenchymal Stem Cells, M. Gnecchi, Ed., vol. 1416 of Methods in Molecular Biology, pp. 89-107, 2016.
145. R. R. Sharma, K. Pollock, A. Hubel, and D. McKenna, "Mesenchymal stem or stromal cells: A review of clinical applications and manufacturing practices, " Transfusion, vol. 54, no. 5, pp. 1418-1437, 2014.
146. N. D'Souza, F. Rossignoli, G. Golinelli et al., "Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies, " BMC Medicine, vol. 13, no. 1, article 186, 2015.
147. Z. Pasha, Y. Wang, R. Sheikh, D. Zhang, T. Zhao, andM. Ashraf, "Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium, " Cardiovascular Research, vol. 77, no. 1, pp. 134-142, 2008.
148. D. Polchert, J. Sobinsky, G. W. Douglas et al., "IFN-activation of mesenchymal stem cells for treatment and prevention of graft versus host disease, " European Journal of Immunology, vol. 38, no. 6, pp. 1745-1755, 2008.